Please login to the form below

Not currently logged in
Email:
Password:

Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative

App

HealthScience communications consultancy Oxford PharmaGenesis has partnered up with digital developer Global Initiative to create an educational, not-for-profit mobile app.

The free Android game - called Dr Bug: Microbe Mayhem - is aimed at children aged seven to 12 and takes children on a journey learning about bacteria, viruses and the use of antibiotics.

The app that was launched at the Oxfordshire Science Festival this month will “stimulate conversations within families about healthcare choices in a way that is enjoyable”, said Dr Dane Comerford, director of the science festival.

“We are delighted that the Oxfordshire Science Festival was the launch pad for the app,” he adds.

The prototype was user-tested by children in years two to six at Aston and Cote Church of England Primary School and Gareth Nixon, Global Initiative’s managing director, said: “The most thrilling thing for us is to be able to broaden minds, and what better place to start than with children?”

“Through our work in digital health, we’ve become more aware of, and frustrated by, the overuse and misuse of antibiotics; the more we can educate about appropriate use at a young age, the better chance we have of averting an antibiotic crisis."

Article by
Gemma Jones

29th June 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics